SIGA Technologies, Inc.

NASDAQ:SIGA

7.11 (USD) • At close October 29, 2024
Bedrijfsnaam SIGA Technologies, Inc.
Symbool SIGA
Munteenheid USD
Prijs 7.11
Beurswaarde 507,435,723
Dividendpercentage 7.64%
52-weken bereik 4.26 - 12.83
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Dr. Phillip Louis Gomez III, M.D., Ph.D.
Website https://www.siga.com

An error occurred while fetching data.

Over SIGA Technologies, Inc.

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla

Vergelijkbare Aandelen

uniQure N.V. logo

uniQure N.V.

QURE

6.42 USD

The Oncology Institute, Inc. logo

The Oncology Institute, Inc.

TOI

0.32 USD

POINT Biopharma Global Inc. logo

POINT Biopharma Global Inc.

PNT

12.5 USD

Rocket Pharmaceuticals, Inc. logo

Rocket Pharmaceuticals, Inc.

RCKT

17.35 USD

Evolus, Inc. logo

Evolus, Inc.

EOLS

16.69 USD

Cross Country Healthcare, Inc. logo

Cross Country Healthcare, Inc.

CCRN

11.84 USD

Design Therapeutics, Inc. logo

Design Therapeutics, Inc.

DSGN

5.41 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)